Curriculum · Metabolic and Endocrine and Diabetes Mellitus
Cushing syndrome
What it is
Cushing syndrome is confirmed hypercortisolism. Once confirmed, its causes split into ACTH-independent disease, which is exogenous glucocorticoids or an adrenal tumor, and ACTH-dependent disease, which is Cushing disease from a pituitary adenoma or ectopic ACTH secretion. In the distribution given, a pituitary adenoma accounts for 80% and an ectopic source for 20% of the ACTH-dependent group, while an adrenal adenoma accounts for 60% and an adrenal carcinoma for 40% of the adrenal group.
How it presents
The syndrome is looked for in a patient presenting with obesity, hypertension, type 2 diabetes mellitus and hirsutism, who also has thin skin and osteopenia.
How it is diagnosed
The diagnosis runs in three steps. Step one is to exclude an exogenous cause, such as drugs or anabolic supplements. Step two is to confirm Cushing syndrome or not, by an abnormal result on any of serum cortisol at morning, 24-hour urinary free cortisol, late-night salivary cortisol, or failure to suppress serum cortisol with low doses of oral dexamethasone; a high random serum cortisol level is not enough to label a patient with Cushing. On the low dose, 1 mg, overnight dexamethasone test a post-dexamethasone cortisol level below 50 nmol/L is considered normal because it suppresses appropriately, while a level above 140 nmol/L confirms hypercortisolemia, and an elevated 24-hour collection showing high urinary free cortisol confirms the presence of Cushing syndrome. The pages differ on how much weight the dexamethasone test still carries: one states that the dexamethasone suppression test, though still commonly used, no longer has a place in the diagnosis and treatment of patients with Cushing syndrome, while the others keep dexamethasone testing at both the low and the high dose in use, so both positions should be held in mind.
Step three establishes the etiology by measuring plasma corticotropin, which separates corticotropin-dependent from corticotropin-independent causes. A low or undetectable ACTH, below 5 pg/mL, is ACTH-independent and points to the adrenal, so CT or MRI of the adrenals follows. A normal to high ACTH, above 20 pg/mL, is ACTH-dependent and points to a non-adrenal source. Pituitary tumors, but not ectopic ones, retain some features of normal regulation of ACTH secretion, so they are suppressed by high-dose dexamethasone and stimulated by CRH. Adequate suppression on the high dose, 8 mg, indicates Cushing disease and an MRI of the pituitary; lack of suppression indicates ectopic ACTH secretion, for example a neuroendocrine tumor or large cell carcinoma, and a CT of the chest, abdomen and pelvis. The CRH stimulation test belongs to the same step, beside the high-dose dexamethasone suppression test rather than after it, and it is read the other way round: a rise in ACTH and cortisol indicates Cushing disease, and no rise in ACTH and cortisol indicates ectopic ACTH secretion with a CT of the chest, abdomen and pelvis. One page gives the whole step as high-dose dexamethasone suppression test plus CRH stimulation test or IPSS. Inferior petrosal sinus sampling is also used when the pituitary MRI is normal or shows an adenoma smaller than 6-9 mm.
On that low dose test, a post-dexamethasone cortisol below 50 nmol/L does not only suppress appropriately, it excludes cortisol excess in most patients.